Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...

Wall Street hits record highs as payrolls surge. Explore healthcare stock movers, obesity drug breakthroughs, AbbVie deals, Centene struggles & ...

Overweight and obesity are growing public health challenges in the Philippines. In just over two decades, the prevalence of overweight and obesity among Filipino adults has doubled, rising from 20% in ...

Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.